
Britain’s health regulators have approved the world’s first pill to treat cases of symptomatic COVID-19. Medicines and Healthcare Products Regulatory Agency (MHRA) said, the antiviral molnupiravir has been found to be safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19, who are at increased risk of developing the disease.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams









2026 Nobel Prize Winners: Categories Wis...
Robert E. Hall and Michael Woodford Win ...
World Bank Mobilises $112 Billion in Pri...

